| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |